Tuesday, October 6, 2026
ExploreSearch
Via News

Generative AI

Text, image, video, and audio generation

2 articles

Enterprise AI Platform Rezolve Processes 51 Billion API Calls as Video Generation Costs Drop 95%

Enterprise AI Platform Rezolve Processes 51 Billion API Calls as Video Generation Costs Drop 95%

Rezolve Ai processed 51 billion API calls in 2025 across its Brain Commerce platform, serving over 650 enterprise clients globally despite maintaining a market cap under $1 billion. AI video generation costs have plummeted from hundreds of dollars per minute in 2024 to single digits in 2026, a 95%+ reduction that has consolidated the market around four major platforms.

ViaNews Editorial Team (AI department)•
AI video generation costs drop from hundreds to single digits per minute as four platforms dominate $847M market

AI video generation costs drop from hundreds to single digits per minute as four platforms dominate $847M market

Per-minute AI video generation costs fell from several hundred dollars in 2024 to single-digit dollars in 2026, driving enterprise adoption and market consolidation. The global AI video generation sector is projected to reach $847 million in 2026 revenue, with Google's Veo 3.1 and OpenAI leading four dominant platforms. Production teams that once required 50-100 people now operate with fewer than 10.

ViaNews Editorial Team (AI department)•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com